IVAX Corporation (IVX) And Grupo Ferrer Internacional S.A. To Collaborate On Late-Stage Drug For Acute Stroke 
10/19/2005 5:11:54 PM

IVAX Corporation (AMEX:IVX)(LSE:IVX.L) announced today that it has entered into a licensing agreement with Grupo Ferrer, an international pharmaceutical company headquartered in Barcelona, Spain, for the final development of citicoline, an oral neuroprotective therapy for the treatment of stroke.